Clinical Trial Update: A Study of Ketamine as an Antidepressant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating ketamine as an antidepressant for major depressive disorder. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: The University of New South Wales | Conditions: Major Depressive Episode | Phase 2 | Status: UNKNOWN